Nobuo Totsuka

445 total citations
10 papers, 361 citations indexed

About

Nobuo Totsuka is a scholar working on Organic Chemistry, Cardiology and Cardiovascular Medicine and Complementary and alternative medicine. According to data from OpenAlex, Nobuo Totsuka has authored 10 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Complementary and alternative medicine. Recurrent topics in Nobuo Totsuka's work include Blood Pressure and Hypertension Studies (2 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Ginkgo biloba and Cashew Applications (2 papers). Nobuo Totsuka is often cited by papers focused on Blood Pressure and Hypertension Studies (2 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Ginkgo biloba and Cashew Applications (2 papers). Nobuo Totsuka collaborates with scholars based in Japan and Brazil. Nobuo Totsuka's co-authors include Koichi Takeya, Hideji Itokawa, Hiroshi Morita, Jean‐Pierre Lepoittevin, Yoshinori Asakawa, Kinzo Watanabe, Eloir Paulo Schenkel, Mário Motidome, Yöichi Iitaka and Mutsumi Inamatsu and has published in prestigious journals such as Clinical Therapeutics, Planta Medica and Chemical and Pharmaceutical Bulletin.

In The Last Decade

Nobuo Totsuka

9 papers receiving 334 citations

Peers

Countries citing papers authored by Nobuo Totsuka

Since Specialization

Citations

This map shows the geographic impact of Nobuo Totsuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Totsuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Totsuka more than expected).

Fields of papers citing papers by Nobuo Totsuka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Totsuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Totsuka. The network helps show where Nobuo Totsuka may publish in the future.

Co-authorship network of co-authors of Nobuo Totsuka

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Totsuka. A scholar is included among the top collaborators of Nobuo Totsuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Totsuka. Nobuo Totsuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Evaluation of the Efficacy and Tolerability of Combination Therapy With Candesartan Cilexetil and Amlodipine Besilate Compared With Candesartan Cilexetil Monotherapy and Amlodipine Besilate Monotherapy in Japanese Patients With Mild-to-Moderate Essential Hypertension: A Multicenter, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study 2012 ·Clinical Therapeutics ·Hiromi Rakugi, Toshio Ogihara, (unknown), (unknown), Nobuo Totsuka	6
2	Efficacy and safety of combination therapy with candesartan cilexetil and pioglitazone hydrochloride in patients with hypertension and type 2 diabetes mellitus 2011 ·Current Medical Research and Opinion ·Kohei Kaku, Kazuaki Enya, (unknown), Nobuo Totsuka	1
3	A Single-Center, Open-Label, Randomized, Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study 2003 ·Current Therapeutic Research ·Nobuo Totsuka, Nobuhisa Awata, Katsuhito Takahashi, Hisako Yamamura, Junko Nakamura, Etsuo Tsuchikane, Yoshiki Kobayashi, Akira Nishibe, Kazuo Terai	1
4	ANTITUMOR SUBSTANCES FROM SOUTH AMERICAN PLANTS 1992 ·Journal of Pharmacobio-Dynamics ·Hideji Itokawa, Koichi Takeya, Kinzo Watanabe, Hiroshi Morita, Yoshitatsu Ichihara, Nobuo Totsuka, Osamu Shirota, (unknown), Motoyoshi Satake, Ichiro Yasuda, Ushio Sankawa, Mário Motidome, (unknown)	1
5	New antitumor principles, casearins A-F, for Casearia sylvestris Sw. (Flacourtiaceae). 1990 ·Chemical and Pharmaceutical Bulletin ·Hideji Itokawa, Nobuo Totsuka, Hiroshi Morita, Koichi Takeya, Yöichi Iitaka, Eloir Paulo Schenkel, Mário Motidome	68
6	A quantitative structure-activity relationship for antitumor activity of long-chain phenols from Ginkgo biloba L. 1989 ·Chemical and Pharmaceutical Bulletin ·Hideji Itokawa, Nobuo Totsuka, (unknown), (unknown), Koichi Takeya, (unknown), Mutsumi Inamatsu, Hiroshi Morita	56
7	Sulfuric acid-catalyzed cyclization of germacrene-D to eudesmane-4,6-diol cyclic sulfate. 1988 ·Chemical and Pharmaceutical Bulletin ·Hideji Itokawa, Hajime Matsumoto, (unknown), Nobuo Totsuka, Kinzo Watanabe	2
8	Antitumor principles from Casearia sylvestris Sw.(Flacourtiaceae). Structure elucidation of new clerodane diterpenes by 2-D NMR spectroscopy. 1988 ·Chemical and Pharmaceutical Bulletin ·Hideji Itokawa, Nobuo Totsuka, Koichi Takeya, Kinzo Watanabe, (unknown)	50
9	Antitumor principles from Ginkgo biloba L. 1987 ·Chemical and Pharmaceutical Bulletin ·(unknown), Nobuo Totsuka, (unknown), Koichi Takeya, Jean‐Pierre Lepoittevin, Yoshinori Asakawa	103
10	Antitumour Principles fromAlpinia galanga 1987 ·Planta Medica ·Hideji Itokawa, Hiroshi Morita, (unknown), Nobuo Totsuka, Koichi Takeya	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact